11 Sep 2017 --- The US Food and Drug Administration (FDA) has made a statement on a new qualified health claim advising that early introduction of peanuts to certain high-risk infants may reduce the risk of peanut allergy. It has responded to a petition for a new claim that states, “for most infants with severe eczema and/or egg allergy who are already eating solid foods, introducing foods containing ground peanuts between 4 and 10 months of age and continuing consumption may reduce the risk of developing peanut allergy by 5 years of age.”
